acetylglucosamine has been researched along with Complications of Diabetes Mellitus in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 11 (64.71) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Maegawa, H; Morino, K | 1 |
| Chatham, JC; Young, ME; Zhang, J | 1 |
| Chen, YB; Gao, X; Hu, T; Li, WR; Liu, HF; Shi, JJ; Tang, D; Wang, Q; Zhang, SJ; Zhang, YB | 1 |
| Cao, L; Kim, G; Reece, EA; Zhao, Z | 1 |
| Katakami, N | 1 |
| Asahi, M; Higuchi, K; Inoue, Y; Moriwaki, K; Takeuchi, T; Ueda, Y | 1 |
| Nie, H; Yi, W | 1 |
| Bers, DM; Copeland, RJ; Dao, K; Despa, F; Erickson, JR; Ferguson, A; Han, G; Hart, GW; Pereira, L; Ripplinger, CM; Wang, L | 1 |
| Bektas, M; Berkowitz, P; Rubenstein, DS; Runager, K | 1 |
| Heo, RW; Jeon, BT; Jeong, EA; Kim, H; Kim, KE; Lee, JY; Roh, GS; Yi, CO | 1 |
| Assmann, A; Carothers, A; Demcheva, M; Fischer, TH; Hechtman, HB; Matthews, J; Muise-Helmericks, RC; Orgill, DP; Perry, S; Pietramaggiori, G; Scherer, SS; Seth, A; Valeri, RC; Vournakis, JN | 1 |
| Issad, T; Masson, E; Pagesy, P | 1 |
| Demcheva, M; Fischer, TH; Gennaoui, A; Matthews, JC; Orgill, DP; Pietramaggiori, G; Scherer, SS; Valeri, CR | 1 |
| Adini, A; Demcheva, M; Erba, P; Orgill, DP; Valeri, CR | 1 |
| Dillmann, W; Gawlowski, T; Han, X; Hoshijima, M; Schwappacher, R; Scott, B; Suarez, J; Torres-Gonzalez, M; Wang, H; Yates, JR | 1 |
| Becker, RE; Burnett, AL; Kramer, MF; Musicki, B | 1 |
| Christeff, N; Gangneux, N; Issad, T; Kuo, M; Zilberfarb, V | 1 |
5 review(s) available for acetylglucosamine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Role of O-linked N-acetylglucosamine in the homeostasis of metabolic organs, and its potential links with diabetes and its complications.
Topics: Acetylglucosamine; Animals; Diabetes Complications; Diabetes Mellitus; Glucose; Homeostasis; Humans; Multiple Organ Failure; Protein Processing, Post-Translational | 2021 |
Role of O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins in diabetic cardiovascular complications.
Topics: Acetylglucosamine; Cardiovascular System; Diabetes Complications; Diabetes Mellitus; Hexosamines; Humans; Protein Processing, Post-Translational | 2021 |
Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus.
Topics: Acetylglucosamine; Animals; Arteries; Atherosclerosis; Cardiovascular Diseases; Diabetes Complications; Disease Progression; Dyslipidemias; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypertension; Inflammation; Insulin Resistance; Mice; Muscle, Smooth, Vascular; Obesity; Oxidative Stress; Polymers; Protein Kinase C; Quality of Life; Reactive Oxygen Species; Risk Factors | 2018 |
O-GlcNAcylation, a sweet link to the pathology of diseases.
Topics: Acetylglucosamine; Animals; Apoptosis; beta-N-Acetylhexosaminidases; Cardiovascular Diseases; Catalysis; Cell Nucleus; Cell Proliferation; Cytoplasm; Diabetes Complications; Diabetes Mellitus, Type 2; Hexosamines; Humans; Insulin; Mitochondria; N-Acetylglucosaminyltransferases; Neoplasms; Neurodegenerative Diseases; Phosphorylation; Protein Processing, Post-Translational; Signal Transduction | 2019 |
O-GlcNAc modification, insulin signaling and diabetic complications.
Topics: Acetylglucosamine; Acetylglucosaminidase; Animals; Diabetes Complications; Feedback, Physiological; Glycosylation; Humans; Hyperglycemia; Insulin; N-Acetylglucosaminyltransferases; Protein Processing, Post-Translational; Receptor, Insulin; Signal Transduction | 2010 |
12 other study(ies) available for acetylglucosamine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Danggui-Shaoyao-San improves cognitive impairment through inhibiting O-GlcNAc-modification of estrogen α receptor in female db/db mice.
Topics: Acetylglucosamine; Animals; Brain Diseases; Cognitive Dysfunction; Diabetes Complications; Drugs, Chinese Herbal; Estrogen Receptor alpha; Female; Gene Expression Regulation; Glucose Tolerance Test; Insulin; Mice; Mice, Inbred NOD; Morris Water Maze Test; Neuroprotective Agents; Phytotherapy | 2021 |
Impact of protein O-GlcNAcylation on neural tube malformation in diabetic embryopathy.
Topics: Acetylglucosamine; Animals; Apoptosis; Blood Glucose; Diabetes Complications; Disease Models, Animal; Endoplasmic Reticulum Stress; Enzyme Activation; Female; Glucose; Glycosylation; Maternal Exposure; Metabolic Networks and Pathways; Mice; N-Acetylglucosaminyltransferases; Neural Tube Defects; Pregnancy; Protein Processing, Post-Translational; Reactive Oxygen Species | 2017 |
Elevated O-GlcNAcylation stabilizes FOXM1 by its reduced degradation through GSK-3β inactivation in a human gastric carcinoma cell line, MKN45 cells.
Topics: Acetylglucosamine; Acylation; beta-N-Acetylhexosaminidases; Cell Line, Tumor; Cell Proliferation; Diabetes Complications; Enzyme Inhibitors; Forkhead Box Protein M1; Glucose; Glycogen Synthase Kinase 3 beta; Humans; Protein Processing, Post-Translational; Protein Stability; Proteolysis; Pyrans; Stomach Neoplasms; Thiazoles; Ubiquitination; Up-Regulation | 2018 |
Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation.
Topics: Acetylglucosamine; Animals; Arrhythmias, Cardiac; Benzylamines; Brain; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Diabetes Complications; Diazooxonorleucine; Enzyme Activation; Glucose; Glycosylation; Humans; Hyperglycemia; Mice; Myocardium; Myocytes, Cardiac; Rats; Sarcoplasmic Reticulum; Sulfonamides | 2013 |
Targeting O-glycosyltransferase (OGT) to promote healing of diabetic skin wounds.
Topics: Acetylglucosamine; Animals; Cell Line; Diabetes Complications; Gene Knockdown Techniques; Glycosylation; Humans; Keratinocytes; Mice; N-Acetylglucosaminyltransferases; Protein Modification, Translational; RNA Interference; Skin; Wound Healing; Wounds and Injuries | 2014 |
Effects of caloric restriction on O-GlcNAcylation, Ca(2+) signaling, and learning impairment in the hippocampus of ob/ob mice.
Topics: Acetylglucosamine; Animals; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Caloric Restriction; Diabetes Complications; Fatty Liver; Hippocampus; Insulin Resistance; Learning; Learning Disabilities; Male; Mice, Inbred C57BL; Mice, Obese; N-Acetylglucosaminyltransferases; Phosphorylation; tau Proteins | 2016 |
Poly-N-acetyl glucosamine nanofibers: a new bioactive material to enhance diabetic wound healing by cell migration and angiogenesis.
Topics: Absorbable Implants; Acetylglucosamine; Animals; Cell Culture Techniques; Cell Movement; Cell Proliferation; Diabetes Complications; Disease Models, Animal; Endothelial Cells; Male; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; Skin Ulcer; Tissue Scaffolds; Wound Healing | 2009 |
Poly-N-acetyl glucosamine fibers induce angiogenesis in ADP inhibitor-treated diabetic mice.
Topics: Acetylglucosamine; Animals; Clopidogrel; Diabetes Complications; Male; Mice; Mice, Inbred C57BL; Nanofibers; Neovascularization, Physiologic; Purinergic P2Y Receptor Antagonists; Ticlopidine; Wound Healing; Wounds and Injuries | 2011 |
Poly-N-acetyl glucosamine fibers are synergistic with vacuum-assisted closure in augmenting the healing response of diabetic mice.
Topics: Acetylglucosamine; Animals; Diabetes Complications; Granulation Tissue; Male; Mice; Mice, Inbred C57BL; Nanofibers; Negative-Pressure Wound Therapy; Time Factors; Wound Healing; Wounds and Injuries | 2011 |
Modulation of dynamin-related protein 1 (DRP1) function by increased O-linked-β-N-acetylglucosamine modification (O-GlcNAc) in cardiac myocytes.
Topics: Acetylation; Acetylglucosamine; Acetylglucosaminidase; Animals; Cytoplasm; Diabetes Complications; Diabetes Mellitus, Experimental; Dynamins; Humans; Membrane Potential, Mitochondrial; Mice; Mitochondria, Heart; Mitochondrial Diseases; Muscle Proteins; Myocytes, Cardiac; Phosphorylation; Protein Transport | 2012 |
Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction.
Topics: Acetylglucosamine; Animals; Diabetes Complications; Disease Models, Animal; Enzyme Activation; Erectile Dysfunction; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Penile Erection; Penis; Phosphorylation; Phosphoserine; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A | 2005 |
[A new mode of reglulation of FoxO1 by O-GlcNAc glycosylation: involvement in the glucotoxicity phenomenon].
Topics: Acetylglucosamine; Diabetes Complications; Forkhead Box Protein O1; Forkhead Transcription Factors; Glucose; Glycogen; Glycolysis; Glycosylation; Hexosamines; Homeostasis; Humans; Models, Biological; Obesity | 2008 |